Anti-vibrio anguillarum vaccine (gava-3) for the prevention of the vibriosis disease in the turbot and salmonidae, and preparation process
CA 2294618 A1 · Owner: Barja Perez, Juan Luis · Inventors: Estevez Toranzo, Alicia; Barja Perez, Juan Luis; Santos Rodriguez, Ysabel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an anti-Vibrio anguillarum vaccine (GAVA-3) for the prevention of vibriosis in the turbot and Salmonidae fish and the process for producing such vaccine. The vaccine is comprised of three bacterial strains of Vibrio angillarum isolated from a turbot: strain CECT 5031 (serotype 01) strain CECT 5032 (serotype 02, sub-group 02.alpha.) and CECT 5033 (serotype 02, sub-group 02.beta.), and is also comprised of their extracellular products. Both the strains and the extracellular products are inactivated with formol. The vaccine applies to the field of aquaculture.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 6, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 6, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 6, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.